These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Observation on the effect of the dust mite sublingual immunotherapy for allergic rhinitis]. Du X, Shu C, Xu G, Ma M, Song H. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Apr; 26(8):372-3. PubMed ID: 22730824 [Abstract] [Full Text] [Related]
5. Efficacy of high-dose sublingual immunotherapy in children allergic to house dust mites in real-life clinical practice. Ferrés J, Justicia JL, García MP, Muñoz-Tudurí M, Alvà V. Allergol Immunopathol (Madr); 2011 Apr; 39(3):122-7. PubMed ID: 20570032 [Abstract] [Full Text] [Related]
6. Safety, tolerability and clinical efficacy of ultra-rush sublingual immunotherapy among patients suffering from allergic rhinitis. Balaji R, Parasuramalu BG, Chandregowda BV, Gangaboraiah. Allergol Immunopathol (Madr); 2014 Apr; 42(3):216-23. PubMed ID: 23481554 [Abstract] [Full Text] [Related]
10. Systemic tolerability of specific subcutaneous immunotherapy with index-of-reactivity-standardized allergen extracts administered using clustered regimens: a retrospective, observational, multicenter study. Serrano P, Justicia JL, Sánchez C, Cimarra M, Fernández-Távora L, Orovitg A, Moreno C, Guerra F, Alvà V. Ann Allergy Asthma Immunol; 2009 Mar; 102(3):247-52. PubMed ID: 19354072 [Abstract] [Full Text] [Related]
11. Children passive smoking jeopardises the efficacy of standard anti-allergic pharmacological therapy, while sublingual immunotherapy withstands. Marogna M, Massolo A, Colombo F, Isella P, Bruno M, Falagiani P. Allergol Immunopathol (Madr); 2011 Mar; 39(2):60-7. PubMed ID: 21216083 [Abstract] [Full Text] [Related]
12. Efficacy of sublingual immunotherapy with house dust mite extract in polyallergen sensitized patients with allergic rhinitis. Lee JE, Choi YS, Kim MS, Han DH, Rhee CS, Lee CH, Kim DY. Ann Allergy Asthma Immunol; 2011 Jul; 107(1):79-84. PubMed ID: 21704889 [Abstract] [Full Text] [Related]
13. Comparative study of cluster and conventional immunotherapy schedules with dermatophagoides pteronyssinus in the treatment of persistent allergic rhinitis. Zhang L, Wang C, Han D, Wang X, Zhao Y, Liu J. Int Arch Allergy Immunol; 2009 Jul; 148(2):161-9. PubMed ID: 18802361 [Abstract] [Full Text] [Related]
14. [Rush immunotherapy of perennial allergic rhinitis]. Ito K. Arerugi; 1989 Nov; 38(11):1246-54. PubMed ID: 2627159 [Abstract] [Full Text] [Related]
16. Clinical and immunologic effects of sublingual immunotherapy on patients with allergic rhinitis to house-dust mites: 1-year follow-up results. Kim ST, Han DH, Moon IJ, Lee CH, Min YG, Rhee CS. Am J Rhinol Allergy; 2010 Nov; 24(4):271-5. PubMed ID: 20819465 [Abstract] [Full Text] [Related]
17. [Clinical efficacy and safety of sublingual immunotherapy using standardized Dermatophagoides farinae extract for children with combined allergic rhinitis and asthma syndrome]. Wen CJ, Zhu MF, Ren WM, Liu XY, Qian H. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 May; 46(5):393-6. PubMed ID: 21781561 [Abstract] [Full Text] [Related]
20. Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures. Pham-Thi N, Scheinmann P, Fadel R, Combebias A, Andre C. Pediatr Allergy Immunol; 2007 Feb; 18(1):47-57. PubMed ID: 17295799 [Abstract] [Full Text] [Related] Page: [Next] [New Search]